Clinical impact of contrast-enhanced computed tomography combined with low-dose ¹⁸F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management

Julia ChalayeDepartment of Nuclear Medicine, Henri Mondor Hospital and Paris-Est University, Créteil, France

Alain LucianiDepartment of Radiology, Henri Mondor Hospital and Paris-Est University, Créteil, France

Catalina EnacheLymphoid Malignancies Unit, Henri Mondor Hospital and Paris-Est University, Créteil, France

Pauline BeaussartDepartment of Radiology, Henri Mondor Hospital and Paris-Est University, Créteil, France

Catherine LhermiteDepartment of Nuclear Medicine, Henri Mondor Hospital and Paris-Est University, Créteil, France

Eva EvangelistaDepartment of Nuclear Medicine, Henri Mondor Hospital and Paris-Est University, Créteil, France

Myriam SasanelliDepartment of Nuclear Medicine, Henri Mondor Hospital and Paris-Est University, Créteil, France

Violaine SafarLymphoid Malignancies Unit, Henri Mondor Hospital and Paris-Est University, Créteil, France

Michel MeignanDepartment of Nuclear Medicine, Henri Mondor Hospital and Paris-Est University, Créteil, France

Corinne HaiounLymphoid Malignancies Unit, Henri Mondor Hospital and Paris-Est University, Créteil, France

Alain RahmouniDepartment of Radiology, Henri Mondor Hospital and Paris-Est University, Créteil, France

Emmanuel IttiDepartment of Nuclear Medicine, Henri Mondor Hospital and Paris-Est University, Créteil, FranceCorrespondence[email protected]

Your download is now in progress and you may close this window